Precision genomics helps patient accomplish goal to run marathon in all 50 states

In the early 2000's, Rebecca Sullivan set a goal to run a marathon in all 50 U.S. states. Doctors diagnosed her with cervical cancer a short time later and medication side effects, including neuropathy, threatened her ability to run. "At first [the neuropathy] was very mild and then in 2020 I was in a clinical trial for a drug and it just really made it much worse," said Rebecca. "Now I just always tell my doctors, when we're making treatment plans, about my lifestyle and what's important to me... I don't want to go on drugs that are going to cause huge problems down the road." About two years ago Rebecca was referred to IU Health Arnett. Her clinical team in Lafayette began genomic testing to find a treatment option that would attack her cancer while also allowing her to stride toward her goal.